Current and historical daily PE Ratio for Cyfuse Biomedical KK (
TSE:4892
) from 2022 to May 11 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Cyfuse Biomedical KK stock (TSE:4892) PE ratio as of May 11 2024 is 0.
More Details
Cyfuse Biomedical KK (TSE:4892) PE Ratio (TTM) Chart
Cyfuse Biomedical KK (TSE:4892) PE Ratio (TTM) Historical Data
View and export this data going back to 2022. Start your Free Trial
Total 354
- 1
- 2
- 3
- 4
| Cyfuse Biomedical KK PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-12 | At Loss | 2024-03-05 | At Loss |
| 2024-05-10 | At Loss | 2024-03-04 | At Loss |
| 2024-05-09 | At Loss | 2024-03-01 | At Loss |
| 2024-05-08 | At Loss | 2024-02-29 | At Loss |
| 2024-05-07 | At Loss | 2024-02-28 | At Loss |
| 2024-05-02 | At Loss | 2024-02-27 | At Loss |
| 2024-05-01 | At Loss | 2024-02-26 | At Loss |
| 2024-04-30 | At Loss | 2024-02-22 | At Loss |
| 2024-04-26 | At Loss | 2024-02-21 | At Loss |
| 2024-04-25 | At Loss | 2024-02-20 | At Loss |
| 2024-04-24 | At Loss | 2024-02-19 | At Loss |
| 2024-04-23 | At Loss | 2024-02-16 | At Loss |
| 2024-04-22 | At Loss | 2024-02-15 | At Loss |
| 2024-04-19 | At Loss | 2024-02-14 | At Loss |
| 2024-04-18 | At Loss | 2024-02-13 | At Loss |
| 2024-04-17 | At Loss | 2024-02-09 | At Loss |
| 2024-04-16 | At Loss | 2024-02-08 | At Loss |
| 2024-04-15 | At Loss | 2024-02-07 | At Loss |
| 2024-04-12 | At Loss | 2024-02-06 | At Loss |
| 2024-04-11 | At Loss | 2024-02-05 | At Loss |
| 2024-04-10 | At Loss | 2024-02-02 | At Loss |
| 2024-04-09 | At Loss | 2024-02-01 | At Loss |
| 2024-04-08 | At Loss | 2024-01-31 | At Loss |
| 2024-04-05 | At Loss | 2024-01-30 | At Loss |
| 2024-04-04 | At Loss | 2024-01-29 | At Loss |
| 2024-04-03 | At Loss | 2024-01-26 | At Loss |
| 2024-04-02 | At Loss | 2024-01-25 | At Loss |
| 2024-04-01 | At Loss | 2024-01-24 | At Loss |
| 2024-03-29 | At Loss | 2024-01-23 | At Loss |
| 2024-03-28 | At Loss | 2024-01-22 | At Loss |
| 2024-03-27 | At Loss | 2024-01-19 | At Loss |
| 2024-03-26 | At Loss | 2024-01-18 | At Loss |
| 2024-03-25 | At Loss | 2024-01-17 | At Loss |
| 2024-03-22 | At Loss | 2024-01-16 | At Loss |
| 2024-03-21 | At Loss | 2024-01-15 | At Loss |
| 2024-03-19 | At Loss | 2024-01-12 | At Loss |
| 2024-03-18 | At Loss | 2024-01-11 | At Loss |
| 2024-03-15 | At Loss | 2024-01-10 | At Loss |
| 2024-03-14 | At Loss | 2024-01-09 | At Loss |
| 2024-03-13 | At Loss | 2024-01-05 | At Loss |
| 2024-03-12 | At Loss | 2024-01-04 | At Loss |
| 2024-03-11 | At Loss | 2023-12-29 | At Loss |
| 2024-03-08 | At Loss | 2023-12-28 | At Loss |
| 2024-03-07 | At Loss | 2023-12-27 | At Loss |
| 2024-03-06 | At Loss | 2023-12-26 | At Loss |
Cyfuse Biomedical KK (TSE:4892) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Cyfuse Biomedical KK
ISIN : JP3311800001
Description
Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine related products.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers